Etofylline clofibrate

• UNSPSC Description:

  Etofylline clofibrate has ypolipidemic and antithrombotic effect. Etofylline clofibrate has an agonistic interaction with intimal PGI2[1].

• Target Antigen:

  Prostaglandin Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/etofylline-clofibrate.html

• Purity:

  99.77

• Solubility:

  DMSO : 52 mg/mL (ultrasonic)

• Smiles:

  ClC(C=C1)=CC=C1OC(C)(C)C(OCCN2C3=C(N(C(N(C)C3=O)=O)C)N=C2)=O

• Molecular Weight:

  420.85

• References & Citations:

  [1]Metz G, et al. Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation. Arzneimittelforschung. 1986 Sep;36(9):1363-5.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  54504-70-0